玻璃体内注射贝伐单抗治疗早产儿视网膜病变的最佳剂量是多少？ - Suppr

Suppr

超能文献

What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?

作者信息

Spandau Ulrich

出版信息

Acta Ophthalmol. 2013 Mar;91(2):e154. doi: 10.1111/j.1755-3768.2012.02552.x. Epub 2012 Sep 19.

DOI:10.1111/j.1755-3768.2012.02552.x

PMID:22989079

Abstract

摘要

相似文献

What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?玻璃体内注射贝伐单抗治疗早产儿视网膜病变的最佳剂量是多少？

Acta Ophthalmol. 2013 Mar;91(2):e154. doi: 10.1111/j.1755-3768.2012.02552.x. Epub 2012 Sep 19.

Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.玻璃体内注射贝伐单抗作为严重早产儿视网膜病变的辅助治疗或单药治疗。

Retina. 2011 Jul-Aug;31(7):1239-47. doi: 10.1097/IAE.0b013e31820d4000.

Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.玻璃体内注射贝伐单抗治疗早产儿视网膜病变：屈光不正结果。

Am J Ophthalmol. 2013 Jun;155(6):1119-1124.e1. doi: 10.1016/j.ajo.2013.01.014. Epub 2013 Mar 12.

Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.单侧注射贝伐单抗治疗早产儿视网膜病变的双侧效应

JAMA Ophthalmol. 2013 Aug;131(8):1099-101. doi: 10.1001/jamaophthalmol.2013.400.

An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan.一项关于贝伐单抗在治疗台湾早产儿阈前期视网膜病变患者中应用的最新研究。

Am J Ophthalmol. 2013 Jan;155(1):150-158.e1. doi: 10.1016/j.ajo.2012.06.010. Epub 2012 Sep 8.

Intravitreal low-dosage bevacizumab for retinopathy of prematurity.玻璃体内低剂量贝伐单抗治疗早产儿视网膜病变。

Acta Ophthalmol. 2014 Sep;92(6):577-81. doi: 10.1111/aos.12266. Epub 2013 Sep 11.

Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.玻璃体腔内超低剂量贝伐单抗治疗早产儿视网膜病变

J Pediatr Ophthalmol Strabismus. 2015 Apr 30;52 Online:e20-1. doi: 10.3928/01913913-20150421-11.

A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.玻璃体内注射贝伐单抗与早产儿视网膜病变中的双嵴形成的罕见关联。

J Pediatr Ophthalmol Strabismus. 2014 Oct 8;51 Online:e66-8. doi: 10.3928/01913913-20140930-01.

Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.玻璃体内注射贝伐单抗后结构变化而无细胞凋亡增加在早产儿视网膜病变模型中的作用。

Acta Ophthalmol. 2012 Sep;90(6):564-70. doi: 10.1111/j.1755-3768.2010.01963.x. Epub 2010 Aug 4.

Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity.尽管对早产儿侵袭性后部视网膜病变进行了积极治疗，但仍发生了视网膜脱离。

J Pediatr Ophthalmol Strabismus. 2010 Dec 22;47 Online:e1-4. doi: 10.3928/01913913-20101217-06.

引用本文的文献

Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries.抗血管内皮生长因子（Anti-VEGF）在早产儿视网膜病变治疗中的作用：基于中等收入国家背景的叙述性综述

Pediatric Health Med Ther. 2023 Feb 15;14:59-69. doi: 10.2147/PHMT.S391591. eCollection 2023.

Pharmacokinetic evaluation of radiolabeled intraocular anti-CLEC14a antibody in preclinical animal species and application in humans.放射性标记的眼内抗 CLEC14a 抗体在临床前动物物种中的药代动力学评估及其在人类中的应用。

Clin Transl Sci. 2022 Dec;15(12):2938-2946. doi: 10.1111/cts.13412. Epub 2022 Sep 27.

Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study.ROP 中玻璃体内雷珠单抗的适当剂量：一项回顾性研究。

BMC Ophthalmol. 2022 Jun 21;22(1):271. doi: 10.1186/s12886-022-02489-6.

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis.玻璃体内注射抗血管内皮生长因子治疗早产儿视网膜病变：一项系统评价和荟萃分析。

Front Med (Lausanne). 2022 May 9;9:884608. doi: 10.3389/fmed.2022.884608. eCollection 2022.

Aggressive posterior retinopathy of prematurity: a review on current understanding.早产儿急性后部型视网膜病变：当前认识的综述。

Eye (Lond). 2021 Apr;35(4):1140-1158. doi: 10.1038/s41433-021-01392-6. Epub 2021 Jan 29.

Allometric Considerations on Proteins Administered Intravitreally to Children.对儿童玻璃体内注射蛋白质的异速生长考量

CPT Pharmacometrics Syst Pharmacol. 2018 Nov;7(11):703-705. doi: 10.1002/psp4.12342. Epub 2018 Aug 22.

Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity.极低剂量玻璃体内注射贝伐单抗治疗早产儿视网膜病变

Ir J Med Sci. 2018 May;187(2):417-421. doi: 10.1007/s11845-017-1684-y. Epub 2017 Oct 7.

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.血管内皮生长因子（VEGF）抑制剂治疗早产儿视网膜病变安全性的系统评价与Meta分析

PLoS One. 2015 Jun 17;10(6):e0129383. doi: 10.1371/journal.pone.0129383. eCollection 2015.

Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?胰岛素样生长因子-1与抗血管内皮生长因子在早产儿视网膜病变中的应用：时机已到？

Neonatology. 2014;106(3):254-60. doi: 10.1159/000365132. Epub 2014 Oct 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验